Authors: Reardon, KA Davis, J Kapsa, RMI Choong, P Byrne, E

Citation: Ka. Reardon et al., Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy, MUSCLE NERV, 24(7), 2001, pp. 893-899

Authors: Reardon, KA Kapsa, RMI Davis, J Kornberg, AJ Austin, L Choong, P Byrne, E

Citation: Ka. Reardon et al., Increased levels of leukemia inhibitory factor mRNA in muscular dystrophy and human muscle trauma, MUSCLE NERV, 23(6), 2000, pp. 962-966

Authors: Reardon, KA Mendelsohn, FAO Chai, SY Horne, MK

Citation: Ka. Reardon et al., The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease, AUST NZ J M, 30(1), 2000, pp. 48-53

Authors: Reardon, KA Scheffer, IE Smith, LJ Jolley, D Horne, MK

Citation: Ka. Reardon et al., How long should a routine EEG be?, J CL NEUROS, 6(6), 1999, pp. 492-493

Authors: Reardon, KA Shiff, M Kempster, PA

Citation: Ka. Reardon et al., Evolution of motor fluctuations in Parkinson's disease: A longitudinal study over 6 years, MOVEMENT D, 14(4), 1999, pp. 605-611